Does ENZALUTAMIDE Cause Central nervous system lesion? 16 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Central nervous system lesion have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.0% of all adverse event reports for ENZALUTAMIDE.
16
Reports of Central nervous system lesion with ENZALUTAMIDE
0.0%
of all ENZALUTAMIDE reports
2
Deaths
14
Hospitalizations
How Dangerous Is Central nervous system lesion From ENZALUTAMIDE?
Of the 16 reports, 2 (12.5%) resulted in death, 14 (87.5%) required hospitalization.
Is Central nervous system lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Central nervous system lesion?
FINGOLIMOD (2,416)
DIMETHYL (1,152)
INTERFERON BETA-1A (978)
NATALIZUMAB (627)
DALFAMPRIDINE (561)
GLATIRAMER (492)
TERIFLUNOMIDE (315)
ADALIMUMAB (229)
OFATUMUMAB (185)
RITUXIMAB (151)
Which ENZALUTAMIDE Alternatives Have Lower Central nervous system lesion Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE